Company patents
AGBIOME, INC.
AGBIOME, INC. exhibits a surprising dual focus, with 61.5% of its portfolio in Peptides & Proteins (pharma_biotech sector) alongside its expected strong presence in Biocides & Pesticides (76.9% of portfolio). While Peptides & Proteins saw a significant 100.0% YoY growth in 2024, both core categories experienced a notable decline in 2025 (Biocides & Pesticides down 55.6% and Peptides & Proteins down 50.0%), suggesting a potential shift in patenting intensity or strategy after a period of rapid expansion.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
26 US filings (since 2023) · 6 categories · 4 themes
Development and application of living organisms (e.g., bacteria, fungi, viruses) or their natural derivatives (e.g., peptides, plant extracts) as agents to suppress or eliminate agricultural pests, weeds, or plant diseases.
Innovation in chemical compounds or optimized formulations specifically designed to control or inhibit the growth of unwanted plants (weeds) in agricultural settings, often with improved selectivity or reduced environmental impact.
Methods and compositions that stimulate a plant's natural defense mechanisms or improve its physiological resilience against pathogens, pests, or environmental stressors, rather than directly eliminating the threat.
Techniques for identifying microorganisms, assessing their viability, quantifying their presence, profiling their metabolic activity, or determining their susceptibility to antimicrobial agents, often in complex biological or environmental samples.
Patents
Showing 1-10 of 56